Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

BOSTON, Feb. 22, 2024 . Elevation Oncology, Inc., an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials